PathologybioRxivPreprint
Targeting the DNM3OS / miR-199a~214 cluster for the treatment of fibroproliferative diseases
G. Savary, M. Buscot, E. Dewaeles…·N. Pottier
This study identifies DNM3OS as a key regulator of fibroblast activation via miRNAs, offering a therapeutic target for fibrotic diseases like IPF.